Logo image of PPH

VANECK PHARMACEUTICAL ETF (PPH) Stock Price, Quote, News and Overview

NASDAQ:PPH - Nasdaq - US92189F6925 - ETF - Currency: USD

91.26  +0.92 (+1.02%)

After market: 91.5 +0.24 (+0.26%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PPH. PPH was compared to 83 industry peers in the Automobile Components industry. PPH has only an average score on both its financial health and profitability. PPH does not seem to be growing, but still is valued expensively. Finally PPH also has an excellent dividend rating. These ratings would make PPH suitable for dividend investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

PPH had positive earnings in the past year.
PPH had a positive operating cash flow in the past year.
In the past 5 years PPH has always been profitable.
PPH had a positive operating cash flow in each of the past 5 years.
PPH Yearly Net Income VS EBIT VS OCF VS FCFPPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B 5B

1.2 Ratios

PPH has a Return On Assets (5.28%) which is comparable to the rest of the industry.
PPH has a Return On Equity (10.77%) which is comparable to the rest of the industry.
The Return On Invested Capital of PPH (9.29%) is comparable to the rest of the industry.
PPH had an Average Return On Invested Capital over the past 3 years of 9.16%. This is in line with the industry average of 9.58%.
The 3 year average ROIC (9.16%) for PPH is below the current ROIC(9.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROIC 9.29%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
PPH Yearly ROA, ROE, ROICPPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 6.93%, PPH is in line with its industry, outperforming 53.01% of the companies in the same industry.
In the last couple of years the Profit Margin of PPH has declined.
PPH has a Operating Margin (12.44%) which is in line with its industry peers.
In the last couple of years the Operating Margin of PPH has remained more or less at the same level.
PPH has a Gross Margin (29.25%) which is comparable to the rest of the industry.
PPH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
PPH Yearly Profit, Operating, Gross MarginsPPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PPH is creating some value.
The number of shares outstanding for PPH remains at a similar level compared to 1 year ago.
The number of shares outstanding for PPH has been reduced compared to 5 years ago.
Compared to 1 year ago, PPH has an improved debt to assets ratio.
PPH Yearly Shares OutstandingPPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
PPH Yearly Total Debt VS Total AssetsPPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

An Altman-Z score of 3.88 indicates that PPH is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.88, PPH belongs to the top of the industry, outperforming 81.93% of the companies in the same industry.
PPH has a debt to FCF ratio of 2.88. This is a good value and a sign of high solvency as PPH would need 2.88 years to pay back of all of its debts.
PPH's Debt to FCF ratio of 2.88 is in line compared to the rest of the industry. PPH outperforms 53.01% of its industry peers.
PPH has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.40, PPH is not doing good in the industry: 60.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Altman-Z 3.88
ROIC/WACC1.27
WACC7.29%
PPH Yearly LT Debt VS Equity VS FCFPPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

PPH has a Current Ratio of 1.82. This is a normal value and indicates that PPH is financially healthy and should not expect problems in meeting its short term obligations.
PPH has a Current ratio of 1.82. This is in the lower half of the industry: PPH underperforms 68.67% of its industry peers.
A Quick Ratio of 1.11 indicates that PPH should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.11, PPH is not doing good in the industry: 69.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.11
PPH Yearly Current Assets VS Current LiabilitesPPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for PPH have decreased strongly by -19.52% in the last year.
Measured over the past 5 years, PPH shows a small growth in Earnings Per Share. The EPS has been growing by 3.63% on average per year.
Looking at the last year, PPH shows a decrease in Revenue. The Revenue has decreased by -5.57% in the last year.
Measured over the past years, PPH shows a small growth in Revenue. The Revenue has been growing by 5.17% on average per year.
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%

3.2 Future

PPH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.57% yearly.
The Revenue is expected to grow by 2.41% on average over the next years.
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PPH Yearly Revenue VS EstimatesPPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
PPH Yearly EPS VS EstimatesPPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 32.59, the valuation of PPH can be described as expensive.
71.08% of the companies in the same industry are cheaper than PPH, based on the Price/Earnings ratio.
PPH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
PPH is valuated rather expensively with a Price/Forward Earnings ratio of 24.67.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PPH indicates a slightly more expensive valuation: PPH is more expensive than 72.29% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, PPH is valued at the same level.
Industry RankSector Rank
PE 32.59
Fwd PE 24.67
PPH Price Earnings VS Forward Price EarningsPPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PPH is valued a bit more expensive than the industry average as 69.88% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PPH indicates a slightly more expensive valuation: PPH is more expensive than 66.27% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.11
EV/EBITDA 11.97
PPH Per share dataPPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PPH does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as PPH's earnings are expected to grow with 12.80% in the coming years.
PEG (NY)1.8
PEG (5Y)8.97
EPS Next 2Y13.1%
EPS Next 3Y12.8%

More info and screens

7

5. Dividend

5.1 Amount

PPH has a Yearly Dividend Yield of 4.04%, which is a nice return.
PPH's Dividend Yield is a higher than the industry average which is at 4.03.
PPH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 4.04%

5.2 History

The dividend of PPH is nicely growing with an annual growth rate of 7.12%!
PPH has paid a dividend for at least 10 years, which is a reliable track record.
PPH has decreased its dividend recently.
Dividend Growth(5Y)7.12%
Div Incr Years1
Div Non Decr Years1
PPH Yearly Dividends per sharePPH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

PPH pays out 50.00% of its income as dividend. This is a bit on the high side, but may be sustainable.
PPH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP50%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
PPH Yearly Income VS Free CF VS DividendPPH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B
PPH Dividend Payout.PPH Dividend Payout, showing the Payout Ratio.PPH Dividend Payout.PayoutRetained Earnings

More info and screens

VANECK PHARMACEUTICAL ETF

NASDAQ:PPH (2/21/2025, 8:00:01 PM)

After market: 91.5 +0.24 (+0.26%)

91.26

+0.92 (+1.02%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-24 2025-04-24
Inst Owners39.74%
Inst Owner Change4.5%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap64.41B
Analysts75.71
Price Target100.67 (10.31%)
Short Float %0.41%
Short Ratio11.51
Dividend
Industry RankSector Rank
Dividend Yield 4.04%
Yearly Dividend1.25
Dividend Growth(5Y)7.12%
DP50%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.09%
PT rev (3m)-6.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.68%
EPS NY rev (3m)-2.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 32.59
Fwd PE 24.67
P/S 2.22
P/FCF 21.11
P/OCF 11.88
P/B 3.46
P/tB 4.72
EV/EBITDA 11.97
EPS(TTM)2.8
EY3.07%
EPS(NY)3.7
Fwd EY4.05%
FCF(TTM)4.32
FCFY4.74%
OCF(TTM)7.68
OCFY8.42%
SpS41.05
BVpS26.41
TBVpS19.32
PEG (NY)1.8
PEG (5Y)8.97
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROCE 12.25%
ROIC 9.29%
ROICexc 10.6%
ROICexgc 13.08%
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
FCFM 10.53%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
ROICexc(3y)10.41%
ROICexc(5y)9.64%
ROICexgc(3y)12.74%
ROICexgc(5y)11.9%
ROCE(3y)12.06%
ROCE(5y)11.19%
ROICexcg growth 3Y13.26%
ROICexcg growth 5Y0.75%
ROICexc growth 3Y14.02%
ROICexc growth 5Y1.17%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Debt/EBITDA 1.31
Cap/Depr 116.24%
Cap/Sales 8.18%
Interest Coverage 10.15
Cash Conversion 96.06%
Profit Quality 152.03%
Current Ratio 1.82
Quick Ratio 1.11
Altman-Z 3.88
F-Score6
WACC7.29%
ROIC/WACC1.27
Cap/Depr(3y)109.9%
Cap/Depr(5y)100.41%
Cap/Sales(3y)7.51%
Cap/Sales(5y)7.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%
EBIT growth 1Y2.68%
EBIT growth 3Y23.2%
EBIT growth 5Y4.75%
EBIT Next Year61.62%
EBIT Next 3Y21.75%
EBIT Next 5Y16.53%
FCF growth 1Y7589.47%
FCF growth 3Y12.46%
FCF growth 5Y21.28%
OCF growth 1Y171.92%
OCF growth 3Y16.24%
OCF growth 5Y13.31%